Waters gains FDA clearance for at-home HPV self-collection kit
Compartilhar
Waters Corporation (NYSE:WAT) reached a significant regulatory milestone on April 8, 2026, with the U.S. Food and Drug Administration granting clearance for the Onclarity HPV Self-Collection Kit and approval for the associated assay for at-home use.
